trending Market Intelligence /marketintelligence/en/news-insights/trending/BVzkYPt8As1Oos9h0h0iYw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Axovant Sciences to raise $40M via common stock offering

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Axovant Sciences to raise $40M via common stock offering

Axovant Sciences Ltd. is planning to raise $40 million in gross proceeds through an underwritten offering of common shares.

The London-based developer of neurological and psychiatric treatments plans to issue 26,666,667 common shares for $1.50 per share as part of the offering.

Axovant Sciences also granted underwriters an option to buy up to an additional 4 million common shares. The offering is expected to close March 18.

Jefferies LLC and Guggenheim Securities LLC are acting as underwriters for the offering.